Status:

COMPLETED

Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19

Lead Sponsor:

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Conditions:

COVID-19

Bacterial Infections

Eligibility:

All Genders

18+ years

Brief Summary

Retrospective single-center cohort study to evaluate the incidence of colonization by multidrug-resistant organisms (MDRO) in mechanically ventilated patients admitted to a large intensive care unit (...

Detailed Description

Bacterial superinfection represents a major treat for patients admitted to intensive care unit (ICU), severely impacting clinical outcome and length of hospital stay. Several studies showed that previ...

Eligibility Criteria

Inclusion

  • COVID-19-related respiratory failure
  • Mechanical ventilation at least 48 hours

Exclusion

  • Age \< 18 years
  • ICU stay \< 48 hours
  • Concurrent participation in other clinical trials is not a criterion for exclusion from this study

Key Trial Info

Start Date :

October 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 30 2022

Estimated Enrollment :

435 Patients enrolled

Trial Details

Trial ID

NCT05293418

Start Date

October 1 2020

End Date

September 30 2022

Last Update

March 7 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation

Milan, MI, Italy, 20122

Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19 | DecenTrialz